NDC Compounded Drug 71285-0215-1 Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride
Solution Intracoronary
Compounded Drug Product Information
NDC Crossover Products Matching Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride
NDC crossover of Maintenance 8 To1 Low K (24 Meq) Ne with NDC 71285-0215 a human compounded drug with other similar products matching the same substance name (Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride) and the same administration route (intracoronary) or dosage form (solution).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
71285-0213-1 | Microplegia High K (100 Meq) 200 Ml, Bag | Microplegia High K (100 Meq) 200 Ml, Bag | 200 mL in 1 BAG | Solution | Intracoronary | Central Admixture Pharmacy Services, Inc. |
71285-0214-1 | Induction 8 To1 High K (70 Meq) Ne | Induction 8 To1 High K (70 Meq) Ne | 300 mL in 1 BAG | Solution | Intracoronary | Central Admixture Pharmacy Services, Inc. |
Frequently Asked Questions
What is the NDC number assigned to Induction 8 To1 High K (70 Meq) Ne?
Induction 8 To1 High K (70 Meq) Ne was assigned by its manufacturer with NDC product code 71285-0215. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Induction 8 To1 High K (70 Meq) Ne?
The NDC package code 71285-0215-1 was assigned to a 300 mL in 1 BAG of magnesium sulfate heptahydrate; sodium chloride; potassium chloride administered intracoronary via solution.
Who manufactures this product?
Induction 8 To1 High K (70 Meq) Ne is manufactured by an outsourced facility and labeled by Central Admixture Pharmacy Services, Inc.. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 2 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Central Admixture Pharmacy Services, Inc. with NDC product codes 71285-0213-1 and 71285-0214-1.